- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kwality Pharmaceuticals Ltd (KWAL)
Kwality Pharmaceuticals Ltd stock price live, this page displays BO KWAL stock exchange data. View the KWAL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kwality Pharmaceuticals Ltd real time stock price chart below.
What Is the Kwality Pharmaceuticals Ltd Stock Price Today?
The Kwality Pharmaceuticals Ltd stock price today is 3,318.75.
What Is the Stock Symbol for Kwality Pharmaceuticals Ltd?
The stock symbol for Kwality Pharmaceuticals Ltd is "KWAL."
What Stock Exchange Does Kwality Pharmaceuticals Ltd Trade On?
Kwality Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Kwality Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Kwality Pharmaceuticals Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KWAL quote. (ISIN: INE552U01010)
What Is the Kwality Pharmaceuticals Ltd Stock Price Today?
The Kwality Pharmaceuticals Ltd stock price today is 3,318.75.
What Is the Stock Symbol for Kwality Pharmaceuticals Ltd?
The stock symbol for Kwality Pharmaceuticals Ltd is "KWAL."
What Stock Exchange Does Kwality Pharmaceuticals Ltd Trade On?
Kwality Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Kwality Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Kwality Pharmaceuticals Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KWAL quote. (ISIN: INE552U01010)
BSE
Currency in INR
3,318.75
+10.35(+0.31%)
Closed·
Fair Value
An estimate of a Kwality Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,237.80
3,362.60
52 wk Range
828.80
3,444.60
KWAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Kwality Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,237.803,362.60
52 wk Range
828.803,444.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
KWAL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kwality Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Kwality Pharmaceuticals Ltd Earnings Call Summary for Q1/2027
- Kwality raised FY2027 revenue guidance to INR 700+ crore from INR 600 crore, targeting EBITDA margins of 26%-27% and INR 1,500 crore by FY2030.
- Shares surged 20% to record high of INR 3,130.85 following upgraded outlook driven by biosimilars, hormones, and complex injectables expansion.
- Q1 FY2027 revenue reached INR 160 crore; gross margin compressed to 53% from 56%-57% due to shift toward lower-margin ROW markets.
- Hormone plant launch scheduled November 2026, oncology expansion by March 2027, with KEYTRUDA biosimilar targeted for commercial launch before end of 2028.
- Management expects debtor days to improve to 165-170 days by FY2027-end from 200 days; planned CapEx of INR 185-190 crore excluding biosimilar trials.
Last Updated: 10/08/2026, 12:52
Read Full TranscriptEarnings
Latest Release
May 19, 2026
EPS / Forecast
24.39 / --
Revenue / Forecast
1.58B / --
Compare KWAL to Peers and Sector
Metrics to compare | KWAL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKWALPeersSector | |
|---|---|---|---|---|
P/E Ratio | 42.5x | 32.4x | −0.3x | |
PEG Ratio | 0.49 | 0.61 | 0.00 | |
Price/Book | 10.4x | 4.3x | 2.6x | |
Price / LTM Sales | 6.2x | 3.8x | 3.1x | |
Upside (Analyst Target) | - | 6.2% | 48.3% | |
Fair Value Upside | Unlock | 1.1% | 6.7% | Unlock |
Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, and various other categories such as general, beta-lactam, cephalosporins, cytotoxic (oncology), and biological. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Kwality Pharma (KWAL) Stock Price Today?
The Kwality Pharma stock price today is 3,318.75 INR.
What Stock Exchange Does Kwality Pharma Trade On?
Kwality Pharma is listed and trades on the Bombay Stock Exchange.
What Is the Stock Symbol for Kwality Pharma?
The stock symbol for Kwality Pharma is "KWAL."
What Is the Kwality Pharma Market Cap?
As of today, Kwality Pharma market cap is 34.44B INR.
What Is Kwality Pharma's Earnings Per Share (TTM)?
The Kwality Pharma EPS (TTM) is 78.10.
From a Technical Analysis Perspective, Is KWAL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Kwality Pharma Stock Split?
Kwality Pharma has split 1 times.
How Many Employees Does Kwality Pharma Have?
Kwality Pharma has 997 employees.
What is the current trading status of Kwality Pharma (KWAL)?
As of Aug 13, 2026, Kwality Pharma (KWAL) is trading at a price of 3,318.75 INR, with a previous close of 3,318.75 INR. The stock has fluctuated within a day range of 3,237.80 INR to 3,362.60 INR, while its 52-week range spans from 828.80 INR to 3,444.60 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.